Investment Rating - The report does not explicitly state an investment rating for the rabies vaccine industry Core Insights - The rabies vaccine market in China is projected to grow from 62.3 billion RMB in 2022 to 72.32 billion RMB in 2023, reflecting a growth rate of 16.09% [22] - The market is segmented into three types of human rabies vaccines: hamster kidney cell, Vero cell, and human diploid cell vaccines, each with distinct market sizes and average prices [22][36] Market Size Overview - The overall rabies vaccine market size from 2017 to 2027 is as follows: - 2017: 44.96 billion RMB - 2018: 40.86 billion RMB - 2019: 37.51 billion RMB - 2020: 54.01 billion RMB - 2021: 66.06 billion RMB - 2022: 62.3 billion RMB - 2023E: 72.32 billion RMB - 2024E: 75.87 billion RMB - 2025E: 80.08 billion RMB - 2026E: 84.35 billion RMB - 2027E: 85.23 billion RMB - The growth rates for these years show fluctuations, with notable increases in 2020 and 2021 [22] Human Rabies Vaccine (Hamster Kidney Cell) - The market size for hamster kidney cell vaccines is projected to decline from 3.64 billion RMB in 2017 to 1.29 billion RMB in 2023E, with a further decrease expected in subsequent years [22][25] - The average price for this type of vaccine has remained stable at 70 RMB per dose from 2017 to 2027 [25] Human Rabies Vaccine (Vero Cell) - The market size for Vero cell vaccines is expected to grow from 38.72 billion RMB in 2017 to 59.23 billion RMB in 2023E, with a slight increase projected in the following years [30] - The average price for Vero cell vaccines has increased from 54 RMB in 2017 to 80 RMB in 2023E [30] Human Rabies Vaccine (Human Diploid Cell) - The market size for human diploid cell vaccines is projected to grow from 2.6 billion RMB in 2017 to 11.8 billion RMB in 2023E, with continued growth expected through 2027 [34] - The average price for this vaccine type has remained stable at 300 RMB per dose from 2023E onwards [34]
中国狂犬疫苗行业市场规模测算逻辑模型 头豹词条报告系列
Tou Bao Yan Jiu Yuan·2024-11-06 12:23